by James DeChene
The CZA Regulatory Advisory Committee met earlier this week for the fifth time. During the meeting, reports were given from the various working groups focusing on individual components of the legislation’s requirements, including how to account for sea level rise, providing financial assurance, and how to monitor bulk product transfer. Of the reports, an agreement of sorts was reached on definitions related to bulk product transfer, while the other topics will be revisited in future meetings based on the amount of material needed to review. Regulations are to be finalized by 10/1/19, and with a little less than a year left, there remains quite a bit of work to be completed.
The State Chamber’s Healthcare & Employer Advocacy and Education Committees hosted a joint event focused on the legal and human resources issues of opioids, drugs and alcohol in the workplace. Attendees were presented with three case studies involving small, medium and large businesses, with a variety of circumstances surrounding employee behavior, benefits and worst-case scenarios.
Next week is the State Chamber’s “Developing Delaware” event taking place in Dover at the Modern Maturity center. Focused on how Delaware compares with surrounding states when reviewed by site selectors, looking at Delaware “By the Numbers” and hearing success stories from around the state, this is a great opportunity to learn about economic development activity happening in Delaware. With over 200 attendees already registered, it will be a great networking event, too. To register, visit: http://web.dscc.com/events/Developing-Delaware-Conversation-Collaboration-Innovation-2175/details
by James DeChene
Two years ago, the State Chamber’s Healthcare Committee held an event on opioids to help employers to identify addiction in the workplace, find assistance for employees struggling with overcoming addiction, and shared examples of innovative employer policies that help to provide treatment options. The event was the first of two planned events, the second of which will be held October 10, 2018, and will be a joint venture between the Healthcare Committee and the Employer Advocacy and Education Committee. We hope you, your HR staff, and other interested people will attend.
Battling opioid and other substance abuse is a nationally recognized issue. Delaware employers are no exception in facing the challenges brought on by this crisis. Join the Delaware State Chamber of Commerce for an informative panel discussion regarding opioid and substance abuse in the workplace. Panelists will share a diverse set of case studies illustrating how employers can and should handle various situations that affect all businesses, from a mom and pop shop, to a large company with internal HR and legal staff.
- Tim Holly , Connolly Gallagher, LLP
- Paula Roy, ROY Associates
- Becky Flood, President & CEO, Ashley Addiction Treatment Center
- Tricia Clendening, SHRM-SCP, GPHR, SPHR, HR Strategies, LLC
- Kevin Fasic, Offit Kurman
- Shannon DeLucia, Hotel DuPont
- Jamie Danner, Senior Benefit Consultant, Kelly Benefit Strategies
Free to attend for DSCC Members / $15 admission for Future Members
Continental Breakfast will be provided
by James DeChene
On the heels of the Carney Administration signing a package of bills this week designed to help combat Delaware’s opioid crisis, the State Chamber will be holding a seminar for employers to learn more about strategies for handling opioids, drugs and alcohol in the workplace.
We will be presenting three employer case examples of opioid and alcohol abuse for panelists to discuss, and offer guidance and advice on how employers can/should handle the situations portrayed. The case studies involve a small “mom and pop” business with no HR capacity, a mid-sized employer (roughly 150 employees) with employee manuals, but no sophisticated HR capacity, and a large employer with in-house HR and legal staffs. The panelists will react to the studies presented, but also add useful insights or advice to Chamber members attending.
Opioids, Drugs and Alcohol in the Workplace
Wednesday, October 10, 2018
9:00 a.m. - 12:00 p.m.
Delaware Art Museum
2301 Kentmere Pkwy., Wilmington, DE 19806
Sponsorship opporunities available. Please contact firstname.lastname@example.org.
by James DeChene
This week in Dover featured the crush of bills needed to be heard before the end of session early morning July 1. Included were: modifications to the WARN Act (Chamber supported), the failure of the legalization of recreational marijuana (Chamber opposed passage), a bill allowing insurance companies to offer ERISA type plans to smaller employers (Chamber supported), and the supplemental spending bill that contains raises for state employees.
Still out there awaiting June 30 action are the bills related to minimum wage, the Workplace Fraud Act, sexual harassment training, and the bond bill, as well as whatever last minute surprises crop up.
In late June, the Supreme Court of the United States released their decision on the highly publicized King v. Burwell case regarding the Patient Protection and Affordable Care Act. The Court considered two possible scenarios in its decision:
The Court’s decision states that subsidies will continue to be available for all eligible consumers who purchase health insurance through the exchange in all states, not just in those with state-based exchanges. Delaware has a “partnership” exchange where the state and federal government work together. There are a significant number of Delawareans currently receiving tax credits to reduce their insurance premiums for the plans purchased through the FFM (Federally-Facilitated Marketplace exchange). Delawareans were at risk of losing their tax credits had the Court ruled under the strict reading of the law.
Now, consumers who purchase health insurance coverage on their own need to focus on what to do next. Here are key dates that consumers should discuss with their agent or broker:
James DeChene is the Chamber's Senior Vice President of Government Affairs.